» Articles » PMID: 38347610

RNA Sequencing Reveals Differential Long Noncoding RNA Expression Profiles in Bacterial and Viral Meningitis in Children

Overview
Publisher Biomed Central
Specialty Genetics
Date 2024 Feb 12
PMID 38347610
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We aimed to investigate the involvement of long non-coding RNA (lncRNA) in bacterial and viral meningitis in children.

Methods: The peripheral blood of five bacterial meningitis patients, five viral meningitis samples, and five healthy individuals were collected for RNA sequencing. Then, the differentially expressed lncRNA and mRNA were detected in bacterial meningitis vs. controls, viral meningitis vs. healthy samples, and bacterial vs. viral meningitis patients. Besides, co-expression and the competing endogenous RNA (ceRNA) networks were constructed. Receiver operating characteristic curve (ROC) analysis was performed.

Results: Compared with the control group, 2 lncRNAs and 32 mRNAs were identified in bacterial meningitis patients, and 115 lncRNAs and 54 mRNAs were detected in viral meningitis. Compared with bacterial meningitis, 165 lncRNAs and 765 mRNAs were identified in viral meningitis. 2 lncRNAs and 31 mRNAs were specific to bacterial meningitis, and 115 lncRNAs and 53 mRNAs were specific to viral meningitis. The function enrichment results indicated that these mRNAs were involved in innate immune response, inflammatory response, and immune system process. A total of 8 and 1401 co-expression relationships were respectively found in bacterial and viral meningitis groups. The ceRNA networks contained 1 lncRNA-mRNA pair and 4 miRNA-mRNA pairs in viral meningitis group. GPR68 and KIF5C, identified in bacterial meningitis co-expression analysis, had an area under the curve (AUC) of 1.00, while the AUC of OR52K2 and CCR5 is 0.883 and 0.698, respectively.

Conclusions: Our research is the first to profile the lncRNAs in bacterial and viral meningitis in children and may provide new insight into understanding meningitis regulatory mechanisms.

References
1.
Soto-Heredero G, Gomez de Las Heras M, Gabande-Rodriguez E, Oller J, Mittelbrunn M . Glycolysis - a key player in the inflammatory response. FEBS J. 2020; 287(16):3350-3369. PMC: 7496292. DOI: 10.1111/febs.15327. View

2.
Torre S, Polyak M, Langlais D, Fodil N, Kennedy J, Radovanovic I . USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. Nat Immunol. 2016; 18(1):54-63. DOI: 10.1038/ni.3581. View

3.
Kotzin J, Iseka F, Wright J, Basavappa M, Clark M, Ali M . The long noncoding RNA regulates CD8 T cells in response to viral infection. Proc Natl Acad Sci U S A. 2019; 116(24):11916-11925. PMC: 6575676. DOI: 10.1073/pnas.1819457116. View

4.
Wang R, Wu Y, Zhu Y, Yao S, Zhu Y . ANKRD22 is a novel therapeutic target for gastric mucosal injury. Biomed Pharmacother. 2022; 147:112649. DOI: 10.1016/j.biopha.2022.112649. View

5.
Salisbury D, Kallapur A, Repetti G, Fraga J, Kim J, Wu X . LncRNAs in Inflammation: Lessons From a Preclinical Investigation of Therapy in Atherosclerosis. JACC Basic Transl Sci. 2022; 7(9):953-955. PMC: 9617122. DOI: 10.1016/j.jacbts.2022.05.009. View